News
BHC
5.81
+3.01%
0.17
Best Value Stocks to Buy for September 22nd
NASDAQ · 12h ago
Weekly Report: what happened at BHC last week (0914-0918)?
Weekly Report · 1d ago
Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Benzinga · 6d ago
Weekly Report: what happened at BHC last week (0907-0911)?
Weekly Report · 09/14 10:23
Bausch Health and YUN expand to Mexico and additional EMEA Markets
TipRanks · 09/08 12:05
Weekly Report: what happened at BHC last week (0831-0904)?
Weekly Report · 09/07 10:16
After Hours Most Active for Sep 2, 2026 : NVDA, HPE, BHC, AVGO, NEE, SNOW, RIVN, ACI, KO, WMT, APLD, RARE
NASDAQ · 09/02 20:24
Weekly Report: what happened at BHC last week (0824-0828)?
Weekly Report · 08/31 10:23
Weekly Report: what happened at BHC last week (0817-0821)?
Weekly Report · 08/24 10:24
Can Bausch (BHC) Run Higher on Rising Earnings Estimates?
NASDAQ · 08/21 16:20
Bausch (BHC) Upgraded to Buy: Here's What You Should Know
NASDAQ · 08/21 16:00
Tuesday's ETF Movers: PPH, PTF
NASDAQ · 08/18 16:08
Canadian Stocks Decline 0.2% In Morning Trading
Dow Jones · 08/18 14:11
This Hedge Fund Portfolio Shrinks 17% as Billionaire Bets Big on Gold
Benzinga · 08/17 17:12
Weekly Report: what happened at BHC last week (0810-0814)?
Weekly Report · 08/17 10:25
Bausch Health put volume heavy and directionally bearish
TipRanks · 08/16 12:49
Paulson takes new stake in Alphabet, exits position in Agnico Eagle Mines
TipRanks · 08/16 12:37
Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial
Seeking Alpha · 08/12 22:30
Prime Medicine: An Initial Prognosis
Seeking Alpha · 08/11 22:06
More
Webull provides a variety of real-time BHC stock news. You can receive the latest news about Bausch Health Companies Inc through multiple platforms. This information may help you make smarter investment decisions.
About BHC
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.